Novo Nordisk Crushes Q1, Wegovy Pill Sales Soar episode artwork

EPISODE · May 6, 2026 · 1 MIN

Novo Nordisk Crushes Q1, Wegovy Pill Sales Soar

from The Daily News Now! Business

Novo Nordisk soars with record-breaking first-quarter sales, driven by their new oral weight-loss pill, Wegovy, which exceeded expectations by doubling forecasts. The company raised its annual profit outlook, with obesity care lineup sales surging twenty-two percent. Despite a slight dip in diabetes staple Ozempic sales, Novo Nordisk remains a strong contender in the weight-loss market. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ac4efceb6f07d3f4

NOW PLAYING

Novo Nordisk Crushes Q1, Wegovy Pill Sales Soar

0:00 1:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on May 6, 2026.

What is this episode about?

Novo Nordisk soars with record-breaking first-quarter sales, driven by their new oral weight-loss pill, Wegovy, which exceeded expectations by doubling forecasts. The company raised its annual profit outlook, with obesity care lineup sales...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!